Orbis Allan Gray’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$134M Buy
2,764,532
+1,201,600
+77% +$58.4M 0.65% 42
2025
Q1
$53.2M Buy
1,562,932
+86,813
+6% +$2.95M 0.3% 53
2024
Q4
$58.1M Buy
+1,476,119
New +$58.1M 0.31% 51